Topical Drug Delivery Market

Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021

Report Code: MD 5119 Mar, 2017, by marketsandmarkets.com

The overall topical drug delivery market is expected to grow from USD 92.40 billion in 2016 to USD 125.88 billion by 2021, at a CAGR of 6.40% from 2016 to 2021. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. Topical drug delivery is a method of drug administration in the body through ophthalmic, rectal, vaginal, and skin as topical routes to achieve its therapeutic effect. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

  • High prevalence of skin diseases
  • Growing preference for topical drug delivery
  • High incidence of burn injuries
  • Rising incidence of diabetes
  • Rising geriatric population

Restraints

  • Negative impact of product recalls  

Opportunities

  • Delivery of biologics through the transdermal route
  • Acquisition of small market players

Challenges

  • Limited therapeutic areas of topical drug delivery

Growing prevalence for topical drug delivery is the major drivers for the market.

Topical drug delivery has the advantage of delivering drugs more selectively to a specific site. Moreover, the use of topical drugs helps avoid fluctuation in drug levels, improves compliance, and facilitates self-medication. As a result, the topical route is preferred over other routes of drug delivery for the treatment of many diseases/conditions. On the other hand, topical delivery involves painless administrations and minimal risk of infections. Considering these advantages, many pharmaceutical companies are developing and launching topical drugs for indications that were traditionally treated using oral or injectable drugs.

The following are the major objectives of the study.

  • To describe and forecast the topical drug delivery market, in terms of value, by product type, route of administration, and facility of use
  • To describe and forecast the topical drug delivery market, in terms of value, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries
  • To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To study the complete value chain of topical drug delivery
  • To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the reed sensor ecosystem
  • To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing competitive landscape for market leaders
  • To analyze strategic approaches such as product launches, acquisitions, contracts, agreements, and partnerships in the reed sensor market

During this research study, major players operating in the topical drug delivery market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Topical Drug Delivery Market

To know about the assumptions considered for the study, download the pdf brochure

The topical drug delivery market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the topical drug delivery market are Galderma S.A. (Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India).

Major Market Developments

  • In January 2017, Johnson & Johnson entered into a definitive agreement to acquire Actelion, a Switzerland-based biotech company, for USD 30 billion. The acquisition gives J&J access to the Swiss group's line of high-price, high-margin medicines for rare diseases.
  • In December 2016, Novartis signed an agreement with Encore Vision, Inc. (U.S.) to acquire the latter’s clinical-stage, disease-modifying, topical treatment for presbyopia.
  • In December 2016, Galderma received approval from the U.S. Food and Drug Administration (FDA) to market Restylane Refyne and Restylane Defyne.
  • In December 2015, Valeant Pharmaceuticals signed an agreement with Walgreens (U.S.) with an aim to extend its distribution model to additional participating independent retail pharmacies.

Target Audience

  • Hospitals and Private Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Academic Institutes
  • Medical Research Institutes
  • Market Research and Consulting Firms
  • Venture Capitalists
  • Suppliers and Distributors of Topical Products

Report Scope

  • Formulation
    • Semi-solids
      • Ointments
      • Creams
      • Gels
      • Lotions
      • Pastes
    • Liquids
      • Suspension
      • Solutions
    • Solids
      • Powders
      • Suppositories
  • Devices (Transdermal Drug Delivery)
    • Patches
    • Gels

Topical Drug Delivery Market, by Route of Administration

  • Skin
  • Ophthalmic
  • Rectal
  • Vaginal
  • Nasal

Topical Drug Delivery Market, by Facility of Use

  • Hospitals and Private Clinics
  • Home Care Settings
  • Other Facilities of Use

Note: Others facilities of use include research institutes and diagnostic centers.

Topical Drug Delivery Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World (RoW)

Critical questions which the report answers

  • What are new application areas which the topical drug delivery companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client’s specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further country-wise breakdown of the market in APAC based on application

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Formulations to grow at the highest CAGR during the forecast period.

Based on product type, the topical drug delivery market is segmented into formulations, and devices. Devices segment is projected to register the highest CAGR during the forecast period. Devices includes transdermal patches and transdermal gels. Devices (Transdermal drug delivery) could replace the injectable mode of delivery required to deliver many new biologic drugs and vaccines. Factors like improved patient compliance, noninvasive nature, elimination of hepatic first pass metabolism, enhancement of therapeutic efficiency, and maintenance of steady plasma level of the drug are contributing to the growth of the transdermal drug delivery devices market.

The global topical drug delivery market is projected to reach USD 125.9 billion by 2021. Market growth can be attributed to factors such as rising prevalence of skin diseases, the convenience of topical drugs, high incidences of burns, rising incidence of diabetes, and growth in geriatric population. Product recalls and their negative impacts on the market are expected to restrict the adoption of topical drugs to a certain extent during the forecast period.

Growing prevalence for topical drug delivery and rapid growth in geriatric population are the major drivers for the market.

Topical drug delivery has the advantage of delivering drugs more selectively to a specific site. Moreover, the use of topical drugs helps avoid fluctuation in drug levels, improves compliance, and facilitates self-medication. As a result, the topical route is preferred over other routes of drug delivery for the treatment of many diseases/conditions. On the other hand, topical delivery involves painless administrations and minimal risk of infections. Considering these advantages, many pharmaceutical companies are developing and launching topical drugs for indications that were traditionally treated using oral or injectable drugs.

Aging is associated with decreased cellular function, which reduces the body’s natural ability to close and heal wounds. As a result, geriatric individuals are major end users of topical drugs for the treatment of wounds. Serious chronic wounds such as pressure ulcers are also very common in the elderly population. With growth in this population segment, the prevalence of several chronic diseases is expected to increase in the coming years, thus driving the demand for convenient drug delivery options, such as topical drug delivery.

However, negative impact of product recalls is restraining the market growth.

Market Dynamics

Topical Drug Delivery Market

Hospitals and private clinics form the fastest growing facility of use segment.

Hospitals and Clinics  

The dominance of this segment in the topical drug delivery market is mainly attributed to the high incidences of skin diseases and disorders requiring hospital treatment and high incidences of hospital-acquired infections (HAIs). Moreover, increasing healthcare spending on drugs in many developed countries is further driving the growth of this segment.

Topical Drug Delivery Market

Home Care Settings

Home care is primarily targeted at patients recovering after a hospital stay or those who need additional support to avoid unnecessary hospitalization. The wide home use of a variety of topical drugs is a major driver of market growth in this segment.

Other facilities of Use

This segment includes academic & research institutions and diagnostic centers that use various topical drug delivery technologies for research purposes or to perform tests.

Key questions

  • Product recall is a major concern in the industry, when will this scenario ease out?
  • Emerging countries have immense opportunities for the growth of topical drug delivery manufacturers, will this scenario continue?
  • Most of the manufactures have opted new product launches and approvals as the key strategies as could be seen from the recent developments. Where will it take the industry in the mid to long term?

The topical drug delivery market is expected to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes.

Topical drug delivery is a method of drug administration in the body through ophthalmic, rectal, vaginal, and skin as topical routes to achieve its therapeutic effect.

The topical drug delivery market has been segmented, on the basis of product type, into formulations and devices (transdermal drug delivery). Transdermal drug delivery is expected to offer lucrative growth opportunities and represents a new revenue pocket for market players. This is because transdermal drug delivery offers enhanced therapeutic efficiency and helps maintain a steady plasma level of the drug.

The topical drug delivery market in APAC is expected to grow at the highest CAGR during the forecast period. The high growth in the Asia-Pacific market can be attributed to the rising geriatric population, increasing healthcare expenditure, rising disposable income, and growing focus of global pharmaceutical companies on the markets in emerging APAC countries.

Topical Drug Delivery Market

Hospitals and Clinics

The dominance of this segment in the topical drug delivery market is mainly attributed to the high incidences of skin diseases and disorders requiring hospital treatment and high incidences of hospital-acquired infections (HAIs). Moreover, increasing healthcare spending on drugs in many developed countries is further driving the growth of this segment.

Home Care Settings

Home care is primarily targeted at patients recovering after a hospital stay or those who need additional support to avoid unnecessary hospitalization. The wide home use of a variety of topical drugs is a major driver of market growth in this segment.

Other facilities of Use

This segment includes academic & research institutions and diagnostic centers that use various topical drug delivery technologies for research purposes or to perform tests.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry applications for topical drug delivery?


In the last few years, the topical drug delivery market has witnessed the recall of numerous products. For instance,

In February 2016, GlaxoSmithKline Philippines voluntarily recalled more than 30 batches of its topical antibiotic cream—Mupirocin Calcium 20 mg/g Cream—due to particulate contamination, including glass particles and rust and paint chips.  In January 2016, Noven Therapeutics (U.S.) voluntarily recalled three strengths of the Daytrana patch. This recall resulted due to the fact that some Daytrana patches did not meet the release liner removal specification. These frequent product recalls are not only creating negative branding for topical drug products but also are resulting in the delayed acceptance of new drugs manufactured by a company whose product has earlier been recalled from the market. This is not only affecting the profitability of companies but also the adoption of topical drug products to a certain extent.

Key players in the market include Galderma S.A. (Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 24)

4 Topical Drug Delivery Market: Premium Insights (Page No. - 27)
    4.1 Global Market, By Route of Administration
    4.2 Global Market, By Product Type
    4.3 Global Market, By End User
    4.4 Geographic Snapshot of the Global Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 High Prevalence of Skin Diseases
           5.3.2 Growing Preference for Topical Drug Delivery
           5.3.3 High Incidence of Burn Injuries
           5.3.4 Rising Incidence of Diabetes
           5.3.5 Rising Geriatric Population
    5.4 Restraints
           5.4.1 Negative Impact of Product Recalls
    5.5 Opportunities
           5.5.1 Delivery of Biologics Through the Transdermal Route
           5.5.2 Acquisition of Small Market Players
    5.6 Challenges
           5.6.1 Limited Therapeutic Areas of Topical Drug Delivery

6 Topical Drug Delivery Market, By Product Type (Page No. - 37)
    6.1 Introduction
           6.1.1 Formulations
                    6.1.1.1 Liquid Topical Formulations
                               6.1.1.1.1 Solutions
                               6.1.1.1.2 Suspensions
                    6.1.1.2 Semi-Solid Topical Formulations
                               6.1.1.2.1 Creams
                               6.1.1.2.2 Gels
                               6.1.1.2.3 Ointments
                               6.1.1.2.4 Pastes
                               6.1.1.2.5 Lotions
                    6.1.1.3 Solid Topical Formulations
                               6.1.1.3.1 Suppositories
                               6.1.1.3.2 Powders
           6.1.2 Devices (Transdermal Drug Delivery)
                    6.1.2.1 Transdermal Patches
                    6.1.2.2 Transdermal Gels

7 Topical Drug Delivery Market, By Route of Administration (Page No. - 52)
    7.1 Introduction
    7.2 Skin Drug Delivery
    7.3 Ophthalmic Drug Delivery
    7.4 Rectal Drug Delivery
    7.5 Vaginal Drug Delivery
    7.6 Nasal Drug Delivery

8 Topical Drug Delivery Market, By Facility of Use (Page No. - 61)
    8.1 Introduction
    8.2 Hospitals and Private Clinics
    8.3 Home Care Settings
    8.4 Other Facilities of Use

9 Topical Drug Delivery Market, By Region (Page No. - 66)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Rest of Europe (RoE)
    9.4 Asia-Pacific (APAC)
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 98)
     10.1 Overview
     10.2 Player Ranking
     10.3 Competitive Situation and Trends
             10.3.1 Product Launches and Approvals
             10.3.2 Acquisitions
             10.3.3 Agreements & Collaborations
             10.3.4 Expansions

11 Company Profiles (Page No. - 106)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Glaxosmithkline PLC
     11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
     11.3 Novartis AG
     11.4 Galderma S.A.
     11.5 Valeant Pharmaceuticals International, Inc.
     11.6 Bayer AG
     11.7 3M Drug Delivery Systems
     11.8 Crescita Therapeutics Inc.
     11.9 Medpharm
     11.10 Cipla

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 139)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Other Developments
     12.5 Available Customizations
     12.6 RT: Real-Time Market Intelligence
     12.7 Related Reports
     12.8 Author Details


List of Tables (87 Tables)

Table 1 Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 2 Topical Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 3 Topical Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 4 Liquid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 5 Liquid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 6 Topical Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 7 Topical Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 8 Semi-Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 9 Semi-Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Topical Creams Market Size, By Region, 2014–2021 (USD Billion)
Table 11 Topical Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 12 Topical Ointments Market Size, By Region, 2014–2021 (USD Billion)
Table 13 Topical Pastes Market Size, By Region, 2014–2021 (USD Billion)
Table 14 Topical Lotions Market Size, By Region, 2014–2021 (USD Billion)
Table 15 Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 16 Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 17 Topical Suppositories Market Size, By Region, 2014–2021 (USD Billion)
Table 18 Topical Powders Market Size, By Region, 2014–2021 (USD Billion)
Table 19 Transdermal Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 20 Transdermal Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 21 Transdermal Patches Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Transdermal Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Topical Drug Delivery Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 24 Some Commercially Available Products
Table 25 Skin Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Commercially Available Products
Table 27 Ophthalmic Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 28 Rectal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 29 Vaginal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 30 Commercially Available Products
Table 31 Nasal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 32 Global Topical Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 33 Market Size for Hospitals and Private Clinics, By Region, 2014–2021 (USD Billion)
Table 34 Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 35 Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 36 Market Size, By Region, 2014-2021 (USD Billion)
Table 37 North America: Topical Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 38 North America: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 39 North America: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 40 North America: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 41 U.S.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 42 U.S.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 43 U.S.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 44 Canada: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 45 Canada: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 46 Canada: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 47 Europe: Market Size, By Country, 2014–2021 (USD Billion)
Table 48 Europe: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 49 Europe: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 50 Europe: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 51 Germany: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 52 Germany: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 53 Germany: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 54 France: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 55 France: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 56 France: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 57 U.K.: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 58 U.K.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 59 U.K.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 60 RoE: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 61 RoE: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 62 RoE: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 63 Asia-Pacific: Topical Drug Delivery Market Size, By Country, 2014–2021 (USD Billion)
Table 64 Asia-Pacific: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 65 Asia-Pacific: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 66 Asia-Pacific: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 67 Japan.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 68 Japan: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 69 Japan: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 70 China: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 71 China: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 72 China: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 73 India: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 74 India: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 75 India: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 76 Rest of Asia-Pacific: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 77 Rest of Asia-Pacific: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 78 Rest of Asia-Pacific: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 79 RoW: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 80 RoW: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 81 RoW: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 82 Topical Drug Delivery Market, By Key Player, 2015
Table 83 Product Launches & Approvals, 2013–2016
Table 84 Acquisitions, 2013–2017
Table 85 Agreements & Collaborations, 2013–2016
Table 86 Expansions, 2013–2017
Table 87 Exchange Rate (Utilized for Conversion of Inr to USD)


List of Figures (41 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Formulations Segment is Expected to Dominate the Global Topical Drug Delivery Market, By Product (2016-2021)
Figure 9 Hospitals and Private Clinics Segment is Expected to Hold Largest Share of the Market, By Facility of Use (2016-2021)
Figure 10 Skin Drug Delivery Segment is Expected to Dominate the Topical Drug Delivery Market, By Route of Administration (2016-2021)
Figure 11 North America is Estimated to Hold the Largest Market Share in 2016, While Asia-Pacific is Expected to Witness Highest Growth (2016-2021)
Figure 12 Global Market Overview: Increasing Prevalence of Skin Diseases is Expected to Be the Key Driver of Market Growth
Figure 13 Formulations Segment is Expected to Dominate the Market, By Product
Figure 14 Skin is Estimated to Command the Largest Share of the Route of Administration Market in 2016
Figure 15 Semi-Solid Formulations Segment is Expected to Grow at the Highest CAGR in the Topical Drug Delivery Formulations Market (2016-2021)
Figure 16 Hospitals and Private Clinics Segment is Expected to Witness the Highest CAGR in the Forecast Period
Figure 17 Asia-Pacific is Expected to Grow at the Highest CAGR (2016-2021)
Figure 18 Topical Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Formulations are Estimated to Command the Larger Share of the Market in 2016
Figure 20 Transdermal Drug Delivery is Expected to Dominate the Market (2016-2021)
Figure 21 Asia-Pacific is Expected to Register the Highest CAGR in the Skin Drug Delivery Market (2016 - 2021)
Figure 22 Hospitals and Private Clinics Segment is Estimated to Command the Largest Share of the Global Market in 2016
Figure 23 Asia-Pacific Hospitals and Private Clinics Market is Expected to Witness Highest CAGR (2016 - 2021)
Figure 24 North America: Topical Drug Delivery Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia-Pacific: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Key Developments in the Global Market, 2013–2017
Figure 29 Market Evolution Framework
Figure 30 Battle for Market Share: Product Launches and Approvals Accounted for the Largest Share of Strategies (2013-2016)
Figure 31 Geographic Revenue Mix of the Top Five Players in the Topical Drug Delivery Market, 2015
Figure 32 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 33 Johnson & Johnson: Company Snapshot (2015)
Figure 34 Novartis AG: Company Snapshot (2015)
Figure 35 Nestlι S.A.: Company Snapshot (2015)
Figure 36 Valeant Pharmaceuticals International, Inc.: Company Snapshot (2015)
Figure 37 Bayer AG: Company Snapshot (2015)
Figure 38 Exchange Rate (Utilized for the Conversion of EUR to USD)
Figure 39 3M: Company Snapshot (2015)
Figure 40 Nuvo Research: Company Snapshot (2015)
Figure 41 Cipla: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 5119
Published ON
Mar, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Topical Drug Delivery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved